Aims and Scope
The Annals of the Rheumatic Diseases is a peer-reviewed medical journal. It is co-owned by the BMJ Group and the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research and abstracts from conferences. The journal was established in 1939. It is available online by subscription and archived editions of the journal (older than one year) are available free of charge. Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Josef Smolen.
Key Metrics
28.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.05 - 0.1
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
>= 25
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
272
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.88
5-Year SI
5-year SI
- 0.87 2-year SI
- 0.85 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Immunology
SJR
- Q1 Immunology
- Q1 Rheumatology
- Q1 Immunology and Allergy
- Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
5.22
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Rheumatoid arthritis
- Connective tissue
- Disease activity
- Gout
- Glucocorticoid
- Ankylosing spondylitis
- Rheumatology
- Lupus erythematosus
- Questionnaire
- Arthritis
- Osteoarthritis
- Allele
- Nuclear magnetic resonance
- Fibromyalgia
- Psoriasis
- Quality of life
- Antigen
- Psoriatic arthritis
- Saliva
- Osteoporosis
Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1935 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Annals of the Rheumatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events
- 12 Apr 24
- Annals of the Rheumatic Diseases
-
Full paper
Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis
- 9 Apr 24
- Annals of the Rheumatic Diseases
-
Full paper
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry
- 9 Apr 24
- Annals of the Rheumatic Diseases
-
Full paper
Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis
- 9 Apr 24
- Annals of the Rheumatic Diseases
-
Full paper
Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al
- 5 Apr 24
- Annals of the Rheumatic Diseases
-
Full paper
Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al
- 5 Apr 24
- Annals of the Rheumatic Diseases
Scite analysis
Powered by scite_
47.3k articles received 671.9k citations see all
- 29,996 Supporting
- 599,544 Mentioning
- 5,203 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 100 Corrections
- 93 Errata
- 0 Expression of Concern
FAQs
How long has Annals of the Rheumatic Diseases been actively publishing?
Annals of the Rheumatic Diseases has been in operation since 1935 till date.
What is the publishing frequency of Annals of the Rheumatic Diseases ?
Annals of the Rheumatic Diseases published with a Monthly frequency.
How many articles did Annals of the Rheumatic Diseases publish last years ?
In 2023, Annals of the Rheumatic Diseases published 3297 articles.
What is the eISSN & pISSN for Annals of the Rheumatic Diseases ?
For Annals of the Rheumatic Diseases,eISSN is 1468-2060 and pISSN is0003-4967.
What is Citescore for Annals of the Rheumatic Diseases ?
Citescore for Annals of the Rheumatic Diseases is 28.5.
What is H index for Annals of the Rheumatic Diseases ?
H index for Annals of the Rheumatic Diseases is 272.
What is SNIP score for Annals of the Rheumatic Diseases ?
SNIP score for Annals of the Rheumatic Diseases is 5.22.
What is the SJR for Annals of the Rheumatic Diseases ?
SJR for Annals of the Rheumatic Diseases is Q1.
Who is the publisher of Annals of the Rheumatic Diseases ?
BMJ PUBLISHING GROUP is the publisher of Annals of the Rheumatic Diseases.